Quantcast

Latest Oligodendroglioma Stories

2014-07-08 08:32:31

("Leading Edge" Gamma Knife Treatment, led by Christopher Duma, M.D., FACS and his team of researchers, offers hope to patients with Glioblastoma Multiforme) NEWPORT BEACH, Calif., July 8, 2014 /PRNewswire/ -- A study on the effects of an aggressive and strategic treatment called "Leading Edge" radiosurgery offers hope to patients diagnosed with life-threatening brain cancer. The study identifies the pathways of invasion of malignant glioma cells and provides a map in which a...

2014-05-31 16:20:13

Single agent NKTR-102 exceeds primary endpoint with fifty-five percent of patients achieving six-week progression-free survival and fifteen percent of patients achieving partial response SAN FRANCISCO, May 31, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of...

MRI-Guided Biopsy For Brain Cancer Improves Diagnosis
2014-05-02 03:14:00

[ Watch The Video: Region’s First MRI-Guided Brain Biopsy At UC San Diego Health System ] UC San Diego Neurosurgeons at UC San Diego Heath System have, for the first time, combined real-time magnetic resonance imaging (MRI) technology with novel non-invasive cellular mapping techniques to develop a new biopsy approach that increases the accuracy of diagnosis for patients with brain cancer. “There are many different types of brain cancer. Making an accurate diagnosis is...

2014-04-09 12:31:14

Three molecularly defined clusters could alter practice; 1 closely resembles deadly glioblastoma Comprehensive genomic analysis of low-grade brain tumors sorts them into three categories, one of which has the molecular hallmarks and shortened survival of glioblastoma multiforme, the most lethal of brain tumors, researchers reported at the American Association for Cancer Research Annual Meeting 2014. "The immediate clinical implication is that a group of patients with tumors previously...

2014-02-04 11:02:59

Presence of IDH1 mutation determines best treatment for malignant astrocytomas Astrocytomas are the most common malignant brain tumors. While most patients' tumors prove to be quite aggressive, outcomes overall can vary widely, with some patients surviving for many years. Now a new study has found that malignant astrocytoma patients whose tumors carry a specific genetic mutation benefit greatly from surgical removal of the largest possible amount of tumor. Preliminary results of the study...

2013-11-23 23:02:03

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Matt Englander for his determination to embrace life despite his battle with brain cancer. New York, NY (PRWEB) November 23, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Matt Englander for his will to live a full life despite his battle with brain cancer. According to a November 13, 2013 article published by ABC News titled...

Genetic Pathway Could Be New Target For Pediatric Tumor Treatment
2013-11-07 11:27:12

redOrbit Staff & Wire Reports - Your Universe Online Low-grade gliomas – a type of pediatric brain tumor that is difficult to care for medically – could potentially be treated using a known genetic pathway, according to new research published in Thursday’s edition of the journal Neuro-Oncology. In laboratory studies, Dr. Fausto Rodriguez, assistant professor of pathology and oncology at Johns Hopkins, and colleagues reported that the mammalian target of the rapamycin (mTOR)...

2013-05-01 15:32:07

A type of low-grade but sometimes lethal brain tumor in children has been found in many cases to contain an unusual mutation that may help to classify, diagnose and guide the treatment of the tumors, report scientists at Dana-Farber Cancer Institute. The researchers led a study of pediatric low-grade gliomas, samples of which were collected through an international consortium organized by brain tumor specialists at Dana-Farber/Children's Hospital Cancer Center. Their findings are being...

2013-03-22 23:04:18

Louis and Phyllis Jacobs Honored for Commitment to Brain Tumor Patients and the ABTA Chicago, IL (PRWEB) March 22, 2013 The American Brain Tumor Association (ABTA) has named Louis and Phyllis Jacobs as the recipients of the 2013 Joel A. Gingras, Jr. Award. For the past 14 years, the Jacobs have supported brain tumor patients and families in their community, as well as supported the ABTA´s brain tumor research funding initiatives. The Joel A. Gingras, Jr. Award is given annually to an...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'